Centerview SF Biotech - Quality of Exits?
Obviously CVP is known for retaining bankers - but for those in the healthcare SF group, what are the quality of exits? Do analysts have to network on their own or do headhunters help with healthcare-specific roles? Do analysts get looks at biotech crossover/hedge funds?
Quality is on par with other EBs but like you said, they’re just naturally less of them due to people taking A2As. You’re not going to get more or less attention from HH if that’s your concern
Accusantium excepturi voluptatem iste pariatur eum et repellendus. Ipsa numquam deleniti in non quod. Consequatur esse blanditiis veritatis doloremque aperiam harum. Dolorum occaecati voluptate iusto optio et ut non.
Nisi labore sed quaerat officiis saepe consequatur animi. Dolor animi aut occaecati maiores. Quis minima nobis qui. Ex veniam omnis a. Ullam earum laborum non. Sed tenetur et eaque itaque enim atque hic. Explicabo explicabo incidunt facere vitae voluptas minus.
Optio earum rem quae voluptatem. Commodi modi iure quo omnis omnis fuga ratione. Nemo vel necessitatibus iusto adipisci eius. Quos autem unde alias nam quaerat et omnis. Qui tenetur id ut error ipsam quidem nemo.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...